greeksoup/ stock research
Stock research / United States / Funds / JGP Global Gestao de Recursos Ltda.

JGP Global Gestao de Recursos Ltda.

CIK 1536562 · latest 13F filed 16 October 2026 · Read the filing on EDGAR

JGP Global Gestao de Recursos Ltda. reported 24 US-listed holdings worth $48.3 million in its 13F for the quarter ended 30 September 2026, filed 16 October 2026. Its largest: XP Inc. (29.6%), I-80 Gold Corp. (20.6%) and SPDR S&P 500 (16.3%). Against the quarter before, it opened 5 positions, added to 13, trimmed 0 and sold out of 10.

Reported holdings$48.3M+7.8% on Q2 2026
Positions24-5 on Q2 2026
The largest ten91.2%of its reported holdings
Latest 13FQ3 2026filed 16 October 2026
Where the money is
OpenedAdded toHeld
XP29.6%IAUX20.6%SPY16.3%PROSY15.3%LLY2.7%ABBV1.6%INCY1.4%JNJ1.3%ONC1.3%MRK1.0%UNH1.0%BMY0.8%VRTX0.8%TMO0.8%10 more5.5%

The 14 largest of its 24 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q2 2026.

Reported holdings, quarter by quarter
Q3 2024: $51.1 million in 39 positions$51.1MQ3 24Q4 2024: $43.9 million in 39 positions$43.9MQ4 24Q1 2025: $130.7 million in 34 positions$131MQ1 25Q2 2025: $204.3 million in 45 positions$204MQ2 25Q3 2025: $171.4 million in 32 positions$171MQ3 25Q4 2025: $168.9 million in 44 positions$169MQ4 25Q1 2026: $22.3 million in 23 positions$22.3MQ1 26Q2 2026: $44.8 million in 29 positions$44.8MQ2 26Q3 2026: $48.3 million in 24 positions$48.3MQ3 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +1.1% over the 2 quarters to 30 September 2026, against +17.3% for the S&P 500.

Its reported holdingsThe S&P 500
90100110120Q1 26Q2 26Q3 26Its holdings +1.1%S&P 500 +17.3%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 5Added 13Held 6Sold out 10
Opened: 5Added: 13Held: 6Sold out: 10

Its positions against its 13F for the quarter to 30 June 2026; a change under 0.1% of a position counts as held

Opened 5

  1. I-80 Gold Corp. IAUX$10.0 million
  2. Kodiak Sciences Inc. KOD$346,589
  3. NVIDIA Corp. NVDA$343,484
  4. Lam Research Corp. LRCX$258,537
  5. ASML Holding N.V. ASML$244,575

Added to 13

  1. Prosus NV PROSY+572,430 shares · +167%
  2. XP Inc. XP+22,547 shares · +3%
  3. Eli Lilly & Co. LLY+32 shares · +3%
  4. AbbVie Inc. ABBV+84 shares · +3%
  5. Johnson & Johnson JNJ+69 shares · +3%
  6. Merck & Co., Inc. MRK+98 shares · +3%
  7. UnitedHealth Group Inc. UNH+36 shares · +3%
  8. Bristol-Myers Squibb Co. BMY+179 shares · +3%

and 5 more in the table below

Sold out of 10

  1. Softbank Group Corp. F SFTBY$4.3 million last quarter
  2. Veon Ltd VEON$3.5 million last quarter
  3. Atai Beckley NV ATAI$2.6 million last quarter
  4. EchoStar Corp. ECHO$2.2 million last quarter
  5. CK Hutchison Holdin-Unsp ADR CKHUY$1.5 million last quarter
  6. Itaú Unibanco Holding S.A. ITUB$1.4 million last quarter
  7. STMicroelectronics N.V. STM$400,512 last quarter
  8. Stryker Corp. SYK$217,554 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
XP Inc. XP679.8K$14.3 million29.57%+22.5K
I-80 Gold Corp. IAUX6.0M$10.0 million20.63%new
SPDR S&P 500 SPY10.3K$7.8 million16.26%no change
Prosus NV PROSY914.8K$7.4 million15.29%+572.4K
Eli Lilly & Co. LLY1.1K$1.3 million2.71%+32
AbbVie Inc. ABBV3.0K$772,9981.60%+84
Incyte Corp. INCY5.6K$681,9871.41%no change
Johnson & Johnson JNJ2.4K$645,1711.34%+69
Beigene, Ltd ONC1.7K$626,1231.30%no change
Merck & Co., Inc. MRK3.5K$504,2261.04%+98
UnitedHealth Group Inc. UNH1.3K$469,4950.97%+36
Bristol-Myers Squibb Co. BMY6.3K$395,1790.82%+179
Vertex Pharmaceuticals Inc. VRTX746$390,0160.81%+21
Thermo Fisher Scientific Inc. TMO549$370,6020.77%+15
Revolution Medicines, Inc. RVMD1.8K$364,9520.76%no change
Kodiak Sciences Inc. KOD3.7K$346,5890.72%new
NVIDIA Corp. NVDA1.5K$343,4840.71%new
Gilead Sciences, Inc. GILD2.2K$327,9100.68%+62
Abbott Laboratories ABT3.0K$292,2400.61%+83
Lam Research Corp. LRCX787$258,5370.54%new
ASML Holding N.V. ASML135$244,5750.51%new
Intuitive Surgical Inc. ISRG583$237,0650.49%+17
Madrigal Pharmaceuticals, Inc. MDGL433$218,2150.45%no change
Oi Sa-Adr50.3K$13,0780.03%no change
Every US-listed position in the fund's 13F for the quarter ended 30 September 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 10 it sold out of are in the box above.

Options it reported

CompanyOptionShares under the optionsValue of those shares
NVIDIA Corp. NVDAPuts6.0K$906,000

1 option lines. A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost; they are not counted in the holdings above.